Europska Unija - hrvatski - EMA (European Medicines Agency)

akebia europe limited - željeznog citrata - hyperphosphatemia; renal dialysis - lijekovi za liječenje hiperkalemije i hiperfosfatemije - fexeric je indiciran za kontrolu hiperfosfatemije u odraslih bolesnika s kroničnom bolesti bubrega (ckd).

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sandoz d.o.o., maksimirska 120, zagreb - tramadolum, paracetamol - tableta - 37,5 mg + 325 mg - urbroj: svaka tableta sadrži 37,5 mg tramadolklorida i 325 mg paracetamola

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sandoz d.o.o., maksimirska 120, zagreb - tramadolum, paracetamol - tableta - 75 mg + 650 mg - urbroj: svaka tableta sadrži 75 mg tramadolklorida i 650 mg paracetamola

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

clinres farmacija d.o.o., zagreb - serum za herpes na usnama

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

santen oy, niittyhaankatu 20, tampere, finska - dorzolamidklorid timololmaleat - kapi za oko, otopina u jednodoznom spremniku - 20 mg/ml + 5 mg/ml - urbroj: 1 ml sadrži 20 mg dorzolamida u obliku dorzolamidklorida i 5 mg timolola u obliku timololmaleata

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

merck sharp & dohme d.o.o., ivana lučića 2a, zagreb - imipenemum, cilastatinum - prašak za otopinu za infuziju - 500 mg/500 mg - urbroj: jedna bočica sadrži imipenem hidrat što odgovara 500 mg imipenema bezvodnog i cilastatinnatrij što odgovara 500 mg cilastatina

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

viennapharm d.o.o. - kalcijumfosfat, kalcijumkarbonat, kamilica, magnezijumfosfat, željezofosfat - pilule - 3.8 mg/1 g+ 3.8 mg/1 g+ 0.8 mg/1 g+ 0.8 mg/1 g+ 0.8 mg/1 g - 1 g pilula sadrži: chamomila recutita d6 3,8 mg + calcium phosphoricum d12 3,8 mg + magnesium phosphoricum c6 0,8 mg + calcium carbonicum hahnemanni dil. c8 0,8 mg + ferrum phosphoricum c8 0,8 mg

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - tramadolklorid paracetamol - tableta - 75 mg + 650 mg - urbroj: jedna tableta sadrži 75 mg tramadolklorida i 650 mg paracetamola

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

vik-dental d.o.o. vladimira preloga 13 10000 zagreb -

Europska Unija - hrvatski - EMA (European Medicines Agency)

sanofi winthrop industrie - dupilumab - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - agenti za dermatitis, isključujući kortikosteroide - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy. asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5. 1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control. prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy. eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.